|
|
| Neuland Laboratories Limited |
|
Financials-Neuland Laboratories Limited| Sector: Bulk Drugs | | BSE:524558 | NSE:NEULANDLAB | Bloomberg:NLL@IN | Reuters:NEUL.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE794A01010 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2021(3) |
| Sales of Products/Services |
2447.05 |
2447.05 |
| Other Operating Income |
0.00 |
0.00 |
| Other Income |
145.97 |
145.97 |
| Total Income |
2593.02 |
2593.02 |
| Total Expenses |
-2349.85 |
-2349.85 |
| OPBDIT |
4942.87 |
4942.87 |
| Interest |
0.00 |
0.00 |
| Depreciation |
-111.41 |
-111.41 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
| Prior Period Adjustments |
0.00 |
0.00 |
| Provision for Tax |
-70.88 |
-70.88 |
| After Tax Profit |
172.28 |
172.28 |
| Equity Capital |
0.00 |
0.00 |
| Reserves |
0.00 |
0.00 |
| Notes to Accounts |
|
|
|
| As on( Months ) |
31-Mar-06(12) |
|
31-Mar-05(12) |
|
31-Mar-04(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
1631.55 |
99.76 |
1529.20 |
99.71 |
1406.71 |
99.75 |
| Operating Income (OI) |
1635.47 |
100.00 |
1533.62 |
100.00 |
1410.23 |
100.00 |
| OPBDIT |
212.27 |
12.98 |
204.94 |
13.36 |
247.80 |
17.57 |
| OPBDT |
152.78 |
9.34 |
141.21 |
9.21 |
178.23 |
12.64 |
| OPBT |
83.67 |
5.12 |
70.17 |
4.58 |
107.01 |
7.59 |
| Non-Operating Income |
3.24 |
0.20 |
2.75 |
0.18 |
1.74 |
0.12 |
| Extraordinary/Prior Period |
16.71 |
1.02 |
-3.06 |
-0.20 |
-97.38 |
-6.91 |
| Tax |
41.27 |
2.52 |
20.96 |
1.37 |
36.50 |
2.59 |
| Profit after tax(PAT) |
62.36 |
3.81 |
48.90 |
3.19 |
-25.12 |
-1.78 |
| Cash Profit |
131.46 |
8.04 |
119.93 |
7.82 |
46.09 |
3.27 |
| Dividend-Equity |
10.93 |
0.67 |
6.55 |
0.43 |
0.00 |
0.00 |
|
| As on |
31-Mar-06 |
|
31-Mar-05 |
|
31-Mar-04 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
767.98 |
53.20 |
702.07 |
55.95 |
620.20 |
53.58 |
| Net Block |
369.12 |
25.57 |
362.15 |
28.86 |
343.89 |
29.71 |
| Capital WIP |
28.71 |
1.99 |
26.13 |
2.08 |
4.60 |
0.40 |
| Investments |
72.72 |
5.04 |
72.72 |
5.80 |
2.31 |
0.20 |
| Inventory |
408.21 |
28.28 |
382.83 |
30.51 |
412.80 |
35.66 |
| Receivables |
289.63 |
20.06 |
195.95 |
15.62 |
211.66 |
18.29 |
| Other Current Assets |
275.19 |
19.06 |
214.97 |
17.13 |
182.31 |
15.75 |
| Balance Sheet Total(BT) |
1443.57 |
100.00 |
1254.73 |
100.00 |
1157.56 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
54.67 |
3.79 |
54.56 |
4.35 |
54.15 |
4.68 |
| Reserves |
439.63 |
30.45 |
375.33 |
29.91 |
317.65 |
27.44 |
| Total Debt |
411.66 |
28.52 |
410.19 |
32.69 |
361.96 |
31.27 |
| Creditors and Acceptances |
340.19 |
23.57 |
251.72 |
20.06 |
315.71 |
27.27 |
| Other current liab/prov. |
197.42 |
13.68 |
162.94 |
12.99 |
108.08 |
9.34 |
| Balance Sheet Total(BT) |
1443.57 |
100.00 |
1254.73 |
100.00 |
1157.56 |
100.00 |
|
| As on |
31-Mar-06 |
31-Mar-05 |
31-Mar-04 |
| OPBIT/Prod.cap.empl.(%) |
17.79 |
18.06 |
24.29 |
| PBIT/Cap. Employed (%) |
18.59 |
16.41 |
11.10 |
| PAT/Networth (%) |
12.62 |
11.37 |
-6.76 |
| Tax/PBT (%) |
39.82 |
30.01 |
320.85 |
| Total Debt/Networth (x) |
0.83 |
0.95 |
0.97 |
| Long Term Debt/Networth (x) |
0.37 |
0.36 |
0.32 |
| PBDIT/Finance Charges (x) |
3.90 |
3.21 |
2.19 |
| Current Ratio (x) |
1.81 |
1.91 |
1.90 |
| RM Inventory (days consumption) |
107.83 |
88.37 |
126.35 |
| FG inventory (days cost of sales) |
36.66 |
37.43 |
39.12 |
| Receivables (days gross sales) |
62.08 |
45.15 |
52.53 |
| Creditors (days cost of sales) |
87.25 |
69.15 |
99.13 |
| Op. curr. assets (days OI) |
213.00 |
186.00 |
203.00 |
|
|
Financials